Asia-Pacific Pharmaceutical: 13 products including cefmetazole sodium for injection are planned to be selected for follow-up procurement.

Asia Pacific Pharmaceuticals announced that the company recently participated in the national centralized procurement of drugs for the renewal of expired varieties. According to the "Announcement of the Proposed Results of the National Centralized Drug Procurement Renewal of Expired Varieties" released by the Renewal Procurement Office on February 10, 2026, the company's 13 products including Cefmetazole Sodium for Injection, Nifedipine Tablets, Pantoprazole Sodium for Injection, and Cefuroxime Axetil Capsules are proposed to be selected in this renewal procurement. The procurement period is from the actual implementation date of the selection results to December 31, 2028.